Primary Vaccination Study With GSK Biologicals' Pneumococcal Vaccine in

See also
Status	Clinical Trial	Phase
Completed	`NCT01641133` - Primary Vaccination With Either Synflorix™ or Prevenar 13™ or Both Vaccines and Booster Vaccination With Synflorix™	Phase 3
Completed	`NCT01204658` - Safety & Immunogenicity of Pneumococcal Vaccine 2189242A Co-administered With DTPa-HBV-IPV/Hib in Healthy Infants	Phase 2
Completed	`NCT00370396` - Safety and Immunogenicity Study of a Booster Dose of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine.	Phase 3
Completed	`NCT02838407` - Identification and Characterization of Bacteria in the Lungs of Children From 6 Months up to 6 Years Old, With Suspected Infection of the Lungs, in Spain.	N/A
Completed	`NCT00523770` - Exploratory Study in Healthy Elderly Subjects to Collect Urine for Development of Assays to Detect S. Pneumoniae	N/A
Completed	`NCT00756067` - Evaluation of Pneumococcal Vaccine Formulations in Elderly	Phase 1
Completed	`NCT00345358` - Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' 10-valent Pneumococcal Conjugate Vaccine	Phase 3
Completed	`NCT01153893` - Immunization of Children Previously Primed With GSK Pneumococcal Vaccine GSK1024850A and of Unprimed Children in Nigeria	Phase 3
Completed	`NCT00307541` - Assess the Immunogenicity of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine	Phase 3
Completed	`NCT00547248` - Pneumococcal Vaccine Booster Study in Healthy Children 12-18 Mths Old Previously Primed With the Same Vaccines	Phase 3
Withdrawn	`NCT01160055` - Study to Characterize and Identify Bacteria Causing Acute Otitis Media in Young Egyptian Children	N/A
Completed	`NCT00370227` - Safety and Immunogenicity Study of a Booster Dose of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine	Phase 3
Completed	`NCT00390910` - Study to Evaluate the Safety and Immunogenicity of a 10-valent Pneumococcal Conjugate Vaccine in Preterm Infants	Phase 3
Completed	`NCT00985751` - Safety & Immunogenicity of Pneumococcal Vaccine 2189242A in Children Aged 12-23 Months at the Time of First Vaccination	Phase 2
Withdrawn	`NCT01031329` - Study to Identify and Characterize Bacteria Causing Acute Otitis Media in Young Children in Turkey	N/A
Completed	`NCT00307554` - A Lot-to-lot Consistency (3 Lots of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine) & Non-inferiority Study	Phase 3
Completed	`NCT02270944` - Safety and Immunogenicity of the Liquid Formulation of Group B Streptococcus Trivalent Vaccine and of the Lyophilized Formulation of Group B Streptococcus Trivalent Vaccine	Phase 2
Completed	`NCT01235949` - Primary and Booster Vaccination Study With Pneumococcal Vaccine GSK1024850A and Prophylactic Antipyretic Treatment	Phase 4
Completed	`NCT00985465` - Immunization of Children Previously Primed With GSK Pneumococcal Vaccine GSK1024850A and of Unprimed Children in Mali	Phase 3
Completed	`NCT00861380` - Evaluation of Effectiveness of GSK Biologicals' Pneumococcal Conjugate Vaccine 1024850A Against Invasive Disease	Phase 3

NCT number	NCT01153841
Study type	Interventional
Source	GlaxoSmithKline
Contact
Status	Completed
Phase	Phase 3
Start date	February 17, 2011
Completion date	July 26, 2011

Primary Vaccination Study With GSK Biologicals' Pneumococcal Vaccine in Healthy Infants in Vietnam

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms